Skip to main content

Open Access Synthesis and characterization of hafnium oxide nanoparticles for bio-safety

Download Article:
In recent years, the perspective of applying hafnium oxide (HfO2) has geared up in various field of medical science such as neutron detection, bioimplants, biosensors, radiotherapy etc., The present study is to synthesis HfO2 nanoparticles, and check its cell viability for in vivo applications. Hafnium oxide nanoparticles of different sizes (8.79, 7.16, 6.78 nm) were synthesized by varying the intervals of stirring time (6 h, 8 h, 12 h) by precipitation method. XRD pattern and Raman spectroscopy revealed that this material crystallizes in a monoclinic structure. SEM images and TEM micrographs showed that the HfO2 NPs were spherical in shape with an average particle size of below 10 nm. The EDAX spectrum showed that the synthesized nanoparticles were HfO2. 3T3 fibroblast cell lines were chosen for cytotoxic study as it mimics the human cells. The aim of this study is to compare the toxicity of different sizes of HfO2 nanoparticles on interaction with 3T3 fibroblast cell lines. From this study we could infer that smaller sized nanoparticles (6.78 and 7.17 nm) have 86% cell viability even at the concentration of 2500 g/mL.

Keywords: BAND GAP; CYTOTOXICITY; HAFNIUM OXIDE; LIFETIME; PARTICLE SIZE

Document Type: Research Article

Publication date: October 1, 2014

More about this publication?
  • Materials Express is a peer-reviewed multidisciplinary journal reporting emerging researches on materials science, engineering, technology and biology. Cutting-edge researches on the synthesis, characterization, properties, and applications of a very wide range of materials are covered for broad readership; from physical sciences to life sciences. In particular, the journal aims to report advanced materials with interesting electronic, magnetic, optical, mechanical and catalytic properties for industrial applications.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content